José Luís Fuster - Concepedia

Author

José Luís Fuster

Hospital Universitario Virgen de la Arrixaca ORCID

Also Known As

Fuster, Jose L., J FUSTER, J Fuster, J L Fuster, J. Fuster, J. L. Fuster, J.L. Fuster, José Luis Fuster, Jose Fuster, Jose L Fuster

113

Publications

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Virgen de la Arrixaca Josep Carreras Leukaemia Research Institute Instituto Murciano de Investigación Biosanitaria Universitat de Barcelona Hospital Sant Joan de Déu Barcelona

About

José Luís Fuster is an author at Hospital Universitario Virgen de la Arrixaca specializing in medicine, hematology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	567
2	Health Sciences	7	7	303
3	Cell Biology	4	4	190
4	Public Health	1	1	132
5	Allergy	1	1	50

José Luís Fuster

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Treatment With All-<i>Trans</i> Retinoic Acid and Anthracycline Monochemotherapy for Children With Acute Promyelocytic Leukemia: A Multicenter Study by the PETHEMA Group Juan Ortega, Luís Madero, Guillermo Martı́n, Journal of Clinical Oncology	2005	134
Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia Diego Sánchez‐Martínez, Matteo Libero Baroni, Francisco Gutiérrez‐Agüera, Blood	2019	132
Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study Sheena Mukkada, Nickhill Bhakta, Guillermo Chantada, The Lancet Oncology Global CharacteristicsPediatric EpidemiologySars-cov-2 InfectionCovid-19 PandemicPediatrics	2021	132
Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes Rafael Díaz de la Guardia, Belén López‐Millán, Jessie R. Lavoie, Stem Cell Reports Cell TherapyDevelopmental BiologyDetailed CharacterizationMedicineHematology	2017	97
Unexpected relevant role of gene mosaicism in patients with primary immunodeficiency diseases Anna Mensa‐Vilaró, María Bravo García‐Morato, Oscar De La Calle-Martin, Journal of Allergy and Clinical Immunology Primary ImmunodeficiencyAutoimmune DiseaseMedicineGeneticsRelevant Role	2018	81
Prognostic significance of FLT3 mutational status and expression levels in MLL-AF4+ and MLL-germline acute lymphoblastic leukemia Carmen Chillón, María Teresa Gómez‐Casares, C E López-Jorge, Leukemia Hematological MalignancyTumor BiologyExpression LevelsMedicineMixed-phenotype Acute Leukemia	2012	64
Detection of occult cerebrospinal fluid involvement during maintenance therapy identifies a group of children with acute lymphoblastic leukemia at high risk for relapse Carolina Martínez‐Laperche, Ana Gómez-García, Álvaro Lassaletta, American Journal of Hematology Mixed-phenotype Acute LeukemiaPathologyGliomaMyeloid NeoplasiaHematological Malignancy	2013	60
l-Asparaginase-Induced Antithrombin Type I Deficiency David Hernández‐Espinosa, Antonia Miñano, Constantino Martı́nez, American Journal Of Pathology L-asparaginase-induced Antithrombin TypeThrombosisThrombopoiesisAllergyAutoimmune Disease	2006	50
Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia Maribel Forero‐Castro, Cristina Robledo, Rocío Benito, British Journal of Cancer	2017	48
NG2 antigen is a therapeutic target for MLL-rearranged B-cell acute lymphoblastic leukemia Belén López‐Millán, Diego Sánchez‐Martínez, Heleia Roca-Ho, Leukemia	2019	48

Page 1